Personality trait dimensions and the pharmacological treatment of borderline personality disorder.

  title={Personality trait dimensions and the pharmacological treatment of borderline personality disorder.},
  author={Erika F. H. Saunders and Kenneth R. Silk},
  journal={Journal of clinical psychopharmacology},
  volume={29 5},
The number of well-designed placebo-controlled studies on pharmacological treatment of borderline personality disorder has been small. We present a breakdown of results of placebo-controlled pharmacological studies, sorting target symptoms into the trait dimensions of affective instability, anxiety inhibition, cognitive-perceptual disturbances, and impulsivity-aggression. Twenty randomized placebo-controlled pharmacological trials studying typical and atypical antipsychotics, selective… CONTINUE READING
9 Citations
44 References
Similar Papers


Publications referenced by this paper.
Showing 1-10 of 44 references

The use of pharmacological treatments for people with personality disorder: a systematic review of randomized controlled trials

  • C Duggan, N Huband, N Smailagic
  • Pers and Men Health
  • 2008
Highly Influential
5 Excerpts

Treatment of aggression Saunders and Silk

  • MK Nickel, C Nickel, P Kaplan
  • Journal of Clinical Psychopharmacology & Volume…
  • 2009

Olanzapine for the treatment of borderline personality disorder: a flexible-dose, 12-week, randomized, double-blind, placebo-controlled study

  • S Schulz, MC Zanarini, H Detke
  • Presented at the 25th Biennial Congress of the…
  • 2006

Similar Papers

Loading similar papers…